Left Atrial Appendage (LAA) Occluders

LAA occluder, Watchman

The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted favorably Dec. 11 in a 13-1 vote that the benefits of the Watchman ...

Lariat Procedure Reduces Stroke Risk in Patients Who Cannot Tolerate Blood Thinn

Shore University Medical Center is one of only a handful of hospitals in the country offering the recent U.S. Food and Drug Administration (FDA)-approved Lariat Suture Delivery Device procedure. Electrophysiologists and interventional cardiologist...

atrial fibrillation, LARIAT
Doctors at the Stony Brook Heart Institute Electrophysiology Lab are using a new nonsurgical technique called the Lariat Suture Delivery Device to treat...
Watchman, LAA occluder, atrial fibrillation
The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted favorably Dec. 11 in a 13-1 vote...
laa occluders structural heart atrial fibrillation atricure atriclip exclusion
AtriCure Inc., a developer of solutions to treat atrial fibrillation, announced the U.S. Food and Drug Administration’s (FDA’s) approval to begin enrollment in...
catheters cath lab ep laa occluders baylis medical torflex transseptal sheath
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Baylis Medical’s TorFlex Transseptal Guiding Sheath Kit device designed for ...
The TigerPaw System II is a mechanical occlusion device developed by LAAx Inc. When implanted, TigerPaw II safely and effectively occludes
The Simbionix Angio Mentor is a virtual reality-training simulator, providing hands-on practice in a simulated environment for endovascular...
A device for excluding the left atrial appendage has received clearance from the FDA. AtriCure, Inc. has received clearance from the U.S....

Articles

atrial fibrillation, LARIAT
Doctors at the Stony Brook Heart Institute Electrophysiology Lab are using a new nonsurgical technique called the Lariat Suture Delivery Device to treat...
Watchman, LAA occluder, atrial fibrillation
The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted favorably Dec. 11 in a 13-1 vote...
laa occluders structural heart atrial fibrillation atricure atriclip exclusion
AtriCure Inc., a developer of solutions to treat atrial fibrillation, announced the U.S. Food and Drug Administration’s (FDA’s) approval to begin enrollment in...
LAA occluder, Watchman
According to Millennium Research Group (MRG), the anticipated Food and Drug Administration (FDA) approval of Boston Scientific's Watchman device will...

Video Center

By Dave Fornell The biggest news item from the American College of Cardiology (ACC) 63rd Annual...
1 week 5 days ago
By Dave Fornell, DAIC editor Data from several cutting-edge device clinical trials will be...
3 weeks 5 days ago
By Dave Fornell, editor I have watched a trend in medical technology grow from a small ripple a...
4 weeks 5 days ago
The webinar will focus on implementation of different strategies to help clinicians reduce radiation exposure during interventional cardiology procedures, both for patient and operators. It will...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve image quality, lesion detection and...
CVIS, cardiovascular information system
This webinar reviews multi-ology, multi-site, vendor neutral solutions that transform rigid departmental information silos into fluid, consolidated, information sharing systems. It discusses how to...